Khiron Life Sciences Looks To Acquire PharmaDrug’s German Subsidiary For $2.0 Million
Khiron Life Sciences Corp. (TSXV: KHRN) announced today the plan to acquire Pharmadrug GmbH, a German cannabis subsidiary of PharmaDrug
Read moreKhiron Life Sciences Corp. (TSXV: KHRN) announced today the plan to acquire Pharmadrug GmbH, a German cannabis subsidiary of PharmaDrug
Read moreKhiron Life Sciences Corp. (TSXV: KHRN) announced today the opening of Zerenia Clinics UK in London. This marks the first
Read moreKhiron Life Sciences Corp. (TSXV: KHRN) announced on Friday after the closing bell that its chief financial officer Joel Friedman
Read moreKhiron Life Sciences (TSXV: KHRN) this morning announced that it is renewing its normal course issuer bid program, which is
Read moreKhiron Life Sciences Corp. (TSXV: KHRN) reported this morning its financial statements for the quarter ending June 30, 2021. The
Read moreKhiron Life Sciences (TSXV: KHRN) announced that it is conducting at $10.0 bought deal private placement this morning. Lead by
Read moreThis morning Khiron Life Sciences Corp (TSXV: KHRN) announced they received the status of National Interest Strategic Project by the Government
Read moreOur first recurring guest on our Spotlight Series is that of Chris Naprawa, whom is now the Chairman of Khiron
Read moreKhiron Life Sciences (TSXV: KHRN) this morning announced the significant development of establishing an exclusive partnership with that of Rappi
Read moreKhiron Life Sciences (TSXV: KHRN) reported its second quarter financials this morning, recording $1.67 million in revenues for the three
Read more